CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Gain (Loss) on Disposition of Assets	$ 2.3
Net sales	2,269.9	$ 1,551.8	$ 6,260.9	$ 4,498.9
Reimbursement Revenue	47.4	0.0	118.7	0.0
Revenues	2,317.3	1,551.8	6,379.6	4,498.9
Cost of sales	1,507.0	980.6	4,098.2	2,842.3
Cost of Reimbursable Expense	47.4	0.0	118.7	0.0
Cost of Revenue	1,554.4	980.6	4,216.9	2,842.3
Gross profit	762.9	571.2	2,162.7	1,656.6
Selling, general and administrative expenses	382.5	305.7	1,217.1	888.5
Amortization of intangibles and other assets	47.1	18.3	126.2	61.3
Restructuring and other special charges	26.4	5.8	59.9	15.4
Operating income	306.9	241.4	759.5	691.4
Other income (expenses):
Interest expense	(55.8)	(25.9)	(218.1)	(77.4)
Equity method income, net	2.1	3.7	7.6	10.4
Investment income	0.4	0.3	1.4	0.9
Other, net	(3.2)	(0.5)	(4.4)	13.9
Earnings before income taxes	250.4	219.0	546.0	639.2
Provision for income taxes	97.3	81.5	222.5	246.5
Net earnings	153.1	137.5	323.5	392.7
Less: Net earnings attributable to the noncontrolling interest	(0.3)	(0.3)	(0.9)	(1.1)
Net earnings attributable to Laboratory Corporation of America Holdings	$ 152.8	$ 137.2	$ 322.6	$ 391.6
Basic earnings per common share (in dollars per share)	$ 1.51	$ 1.62	$ 3.29	$ 4.61
Diluted earnings per common share (in dollars per share)	$ 1.49	$ 1.59	$ 3.24	$ 4.53
Covance [Member]
Revenues	$ 647.0		$ 1,535.0
Other income (expenses):
Net earnings attributable to Laboratory Corporation of America Holdings	$ 27.8		$ 7.4